Short Interest in Heart Test Laboratories, Inc. (NASDAQ:HSCS) Declines By 13.5%

Heart Test Laboratories, Inc. (NASDAQ:HSCS) was the target of a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 33,300 shares, a decrease of 13.5% from the January 15th total of 38,500 shares. Approximately 4.1% of the company’s shares are short sold. Based on an average daily trading volume, of 35,000 shares, the short-interest ratio is currently 1.0 days.

Heart Test Laboratories Price Performance

Shares of Heart Test Laboratories stock traded up $0.10 during trading on Friday, reaching $3.91. 19,626 shares of the stock were exchanged, compared to its average volume of 17,597. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.52 and a current ratio of 1.72. The stock’s fifty day moving average is $3.62 and its 200 day moving average is $3.44. Heart Test Laboratories has a 1 year low of $2.36 and a 1 year high of $18.50.

Heart Test Laboratories (NASDAQ:HSCS) last posted its earnings results on Monday, December 16th. The company reported ($2.27) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.30) by $0.03. During the same quarter in the previous year, the business earned ($15.92) EPS. Sell-side analysts predict that Heart Test Laboratories will post -10.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Maxim Group reiterated a “buy” rating and set a $12.00 target price on shares of Heart Test Laboratories in a report on Wednesday, December 18th.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.